Catalent provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The company was founded in 2007 and is founded in Somerset, New Jersey.
According to the new market research report "Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) - Global Forecast to 2025",
A report by The Insight Partner's on the global Starch Softgel Capsules Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics
On September 8, the SP500 committee said "No" to Tesla (Nasdaq:TSLA) and published the 3 candidates to be included in the SP500: Etsy (Nasdaq:ETSY), Catalent (NYSE:CTLT) and Teradyne (Nasdaq:TER). There was much speculation about the possible incorporation of Tesla to the famous stock index, but, contrary to the forecasts that...
Francisco Javier Garcia on Seeking Alpha | September 25, 2020
One thing that has been driving Tesla stock recently is the expectation that it would be added to the S&P 500. However, that didn’t happen, and investors started unloading the shares as a result. The S&P 500 Index Committee added Catalent, Etsy and Teradyne to the index on Friday, but it excluded Tesla stock. Q2 […] The post Tesla stock tanks after capital raise, S&P 500 doesn’t add it appeared first on ValueWalk .